Europe Heparin Market By Type (Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin), By Application (Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications), By Route of Administration (Subcutaneous and Intravenous), By End Use (Outpatient and Inpatient), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

The Europe Heparin Market would witness market growth of 6.2% CAGR during the forecast period (2021-2027).

The demand for anticoagulants is very high and it is anticipated to boost the overall heparin market. Moreover, the increased healthcare expenditures and growing awareness levels among the patient are the major factors expected to drive the global heparin market over the forecast period.

The growing burden of chronic diseases is the main factor for the growth of the heparin market. As per the World Health Organization, chronic diseases are a massive global challenge for decades and account for almost 60% of all deaths across the globe. The worldwide burden of chronic diseases may reach 57% by the end of 2020.

In the past few decades, it has been reported that there are increasing incidences of venous thrombosis and cardiovascular diseases across the globe including heart attacks and strokes. It is the major factor that is driving the growth of the global heparin market. Moreover, as heparin is used in various surgeries including orthopaedic and heart surgeries, and rise in the number of patients undergoing such surgeries would further boost the growth of the heparin market. Cardiovascular diseases have a direct impact on the heparin market growth.

The demand for heparin is high in European counties. It is due to the increasing adoption of technologically advanced products in the healthcare sector in this region. The increasing number of patients who are suffering from cardiovascular diseases is very high among the region’s population. This will open new growth avenues in the heparin market in this region. The medical infrastructure is very advanced in the UK. The whole population’s medical expenses are covered by the National Health System. It is financed through general taxation and independently-run by the Department of Health. The major cause of death in the UK is due to coronary heart disease (CHD). The use of heparin in the treatment of CHD is increasing exponentially. Thus, it is expected that the demand for heparin will increase in the forecast period and positively contribute to the growth of the market. Although there is a decline in death rates due to cardiovascular disease (CVD) in the UK, rates are still comparatively high than other Western European countries.

The Germany market dominated the Europe Venous Thromboembolism Market by Country 2020, thereby, achieving a market value of $100.2 million by 2027. The UK market is exhibiting a CAGR of 6.7% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 8.2% during (2021 - 2027).

Based on Type, the market is segmented into Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin. Based on Application, the market is segmented into Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications. Based on Route of Administration, the market is segmented into Subcutaneous and Intravenous. Based on End Use, the market is segmented into Outpatient and Inpatient. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Heparin Market Size will Hit $10 Billion by 2027, at a CAGR of 6.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer, Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, and Viatris, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Low Molecular Weight Heparin
• Unfractionated Heparin
• Ultra-low Molecular Weight Heparin

By Application

• Atrial Fibrillation
• Coronary Artery Disease
• Venous Thromboembolism
• Renal Impairment
• Other Applications

By Route of Administration

• Subcutaneous
• Intravenous

By End Use

• Outpatient
• Inpatient

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Baxter International, Inc.
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Pfizer, Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries Ltd.
• Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
• Dr. Reddy’s Laboratories Ltd.
• LEO Pharma A/S
• Viatris, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Heparin Market, by Type
1.4.2 Europe Heparin Market, by Application
1.4.3 Europe Heparin Market, by Route of Administration
1.4.4 Europe Heparin Market, by End Use
1.4.5 Europe Heparin Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Heparin Market by Type
3.1 Europe Low Molecular Weight Heparin Market by Country
3.2 Europe Unfractionated Heparin Market by Country
3.3 Europe Ultra-low Molecular Weight Heparin Market by Country

Chapter 4. Europe Heparin Market by Application
4.1 Europe Atrial Fibrillation Market by Country
4.2 Europe Coronary Artery Disease Market by Country
4.3 Europe Venous Thromboembolism Market by Country
4.4 Europe Renal Impairment Market by Country
4.5 Europe Other Applications Market by Country

Chapter 5. Europe Heparin Market by Route of Administration
5.1 Europe Subcutaneous Market by Region
5.2 Europe Intravenous Market by Region

Chapter 6. Europe Heparin Market by End Use
6.1 Europe Outpatient Market by Country
6.2 Europe Inpatient Market by Country

Chapter 7. Europe Heparin Market by Region
7.1 Germany Heparin Market
7.1.1 Germany Heparin Market by Type
7.1.2 Germany Heparin Market by Application
7.1.3 Germany Heparin Market by Route of Administration
7.1.4 Germany Heparin Market by End Use
7.2 UK Heparin Market
7.2.1 UK Heparin Market by Type
7.2.2 UK Heparin Market by Application
7.2.3 UK Heparin Market by Route of Administration
7.2.4 UK Heparin Market by End Use
7.3 France Heparin Market
7.3.1 France Heparin Market by Type
7.3.2 France Heparin Market by Application
7.3.3 France Heparin Market by Route of Administration
7.3.4 France Heparin Market by End Use
7.4 Russia Heparin Market
7.4.1 Russia Heparin Market by Type
7.4.2 Russia Heparin Market by Application
7.4.3 Russia Heparin Market by Route of Administration
7.4.4 Russia Heparin Market by End Use
7.5 Spain Heparin Market
7.5.1 Spain Heparin Market by Type
7.5.2 Spain Heparin Market by Application
7.5.3 Spain Heparin Market by Route of Administration
7.5.4 Spain Heparin Market by End Use
7.6 Italy Heparin Market
7.6.1 Italy Heparin Market by Type
7.6.2 Italy Heparin Market by Application
7.6.3 Italy Heparin Market by Route of Administration
7.6.4 Italy Heparin Market by End Use
7.7 Rest of Europe Heparin Market
7.7.1 Rest of Europe Heparin Market by Type
7.7.2 Rest of Europe Heparin Market by Application
7.7.3 Rest of Europe Heparin Market by Route of Administration
7.7.4 Rest of Europe Heparin Market by End Use

Chapter 8. Company Profiles
8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Fresenius SE & Co. KGaA
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.1 Recent strategies and developments:
8.3.1.1 Partnerships, Collaborations, and Agreements:
8.3.1.2 Acquisition and Mergers:
8.3.1.3 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Sanofi S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
8.7.1 Company Overview
8.8 Dr. Reddy’s Laboratories Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 LEO Pharma A/S
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. Viatris, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense

TABLE 1 Europe Heparin Market, 2017 - 2020, USD Million
TABLE 2 Europe Heparin Market, 2021 - 2027, USD Million
TABLE 3 Europe Heparin Market by Type, 2017 - 2020, USD Million
TABLE 4 Europe Heparin Market by Type, 2021 - 2027, USD Million
TABLE 5 Europe Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 7 Europe Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 9 Europe Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Heparin Market by Application, 2017 - 2020, USD Million
TABLE 12 Europe Heparin Market by Application, 2021 - 2027, USD Million
TABLE 13 Europe Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 21 Europe Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 24 Europe Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 25 Europe Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 26 Europe Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 27 Europe Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 28 Europe Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 29 Europe Heparin Market by End use, 2017 - 2020, USD Million
TABLE 30 Europe Heparin Market by End USe, 2021 - 2027, USD Million
TABLE 31 Europe Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 32 Europe Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 33 Europe Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 34 Europe Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 35 Europe Heparin Market by Region, 2017 - 2020, USD Million
TABLE 36 Europe Heparin Market by Region, 2021 - 2027, USD Million
TABLE 37 Germany Heparin Market, 2017 - 2020, USD Million
TABLE 38 Germany Heparin Market, 2021 - 2027, USD Million
TABLE 39 Germany Heparin Market by Type, 2017 - 2020, USD Million
TABLE 40 Germany Heparin Market by Type, 2021 - 2027, USD Million
TABLE 41 Germany Heparin Market by Application, 2017 - 2020, USD Million
TABLE 42 Germany Heparin Market by Application, 2021 - 2027, USD Million
TABLE 43 Germany Heparin Market by route of Administration, 2017 - 2020, USD Million
TABLE 44 Germany Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 45 Germany Heparin Market by End USE, 2017 - 2020, USD Million
TABLE 46 Germany Ultra-Heparin Market by end Use, 2021 - 2027, USD Million
TABLE 47 UK Heparin Market, 2017 - 2020, USD Million
TABLE 48 UK Heparin Market, 2021 - 2027, USD Million
TABLE 49 UK Heparin Market by Type, 2017 - 2020, USD Million
TABLE 50 UK Heparin Market by Type, 2021 - 2027, USD Million
TABLE 51 UK Heparin Market by Application, 2017 - 2020, USD Million
TABLE 52 UK Heparin Market by Application, 2021 - 2027, USD Million
TABLE 53 UK Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 54 UK Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 55 UK Heparin Market by end use, 2017 - 2020, USD Million
TABLE 56 UK Heparin Market by Application, 2021 - 2027, USD Million
TABLE 57 France Heparin Market, 2017 - 2020, USD Million
TABLE 58 France Heparin Market, 2021 - 2027, USD Million
TABLE 59 France Heparin Market by Type, 2017 - 2020, USD Million
TABLE 60 France Heparin Market by Type, 2021 - 2027, USD Million
TABLE 61 France Heparin Market by Application, 2017 - 2020, USD Million
TABLE 62 France Heparin Market by Application, 2021 - 2027, USD Million
TABLE 63 France Heparin Market by Route of administration, 2017 - 2020, USD Million
TABLE 64 France Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 65 France Heparin Market by end use, 2017 - 2020, USD Million
TABLE 66 France Heparin Market by END USE, 2021 - 2027, USD Million
TABLE 67 Russia Heparin Market, 2017 - 2020, USD Million
TABLE 68 Russia Heparin Market, 2021 - 2027, USD Million
TABLE 69 Russia Heparin Market by Type, 2017 - 2020, USD Million
TABLE 70 Russia Heparin Market by Type, 2021 - 2027, USD Million
TABLE 71 Russia Heparin Market by Application, 2017 - 2020, USD Million
TABLE 72 Russia Heparin Market by Application, 2021 - 2027, USD Million
TABLE 73 Russia Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 74 Russia Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 75 Russia Heparin Market by End USe, 2017 - 2020, USD Million
TABLE 76 Russia Ultra-Heparin Market by end use, 2021 - 2027, USD Million
TABLE 77 Spain Heparin Market, 2017 - 2020, USD Million
TABLE 78 Spain Heparin Market, 2021 - 2027, USD Million
TABLE 79 Spain Heparin Market by Type, 2017 - 2020, USD Million
TABLE 80 Spain Heparin Market by Type, 2021 - 2027, USD Million
TABLE 81 Spain Heparin Market by Application, 2017 - 2020, USD Million
TABLE 82 Spain Heparin Market by Application, 2021 - 2027, USD Million
TABLE 83 Spain Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 84 Spain Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 85 Spain Heparin Market by End use, 2017 - 2020, USD Million
TABLE 86 Spain Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 87 Italy Heparin Market, 2017 - 2020, USD Million
TABLE 88 Italy Heparin Market, 2021 - 2027, USD Million
TABLE 89 Italy Heparin Market by Type, 2017 - 2020, USD Million
TABLE 90 Italy Heparin Market by Type, 2021 - 2027, USD Million
TABLE 91 Italy Heparin Market by Application, 2017 - 2020, USD Million
TABLE 92 Italy Heparin Market by Application, 2021 - 2027, USD Million
TABLE 93 Italy Heparin Market by route of administration, 2017 - 2020, USD Million
TABLE 94 Italy Heparin Market by route of administration, 2021 - 2027, USD Million
TABLE 95 Italy Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 96 Italy Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 97 Rest of Europe Heparin Market, 2017 - 2020, USD Million
TABLE 98 Rest of Europe Heparin Market, 2021 - 2027, USD Million
TABLE 99 Rest of Europe Heparin Market by Type, 2017 - 2020, USD Million
TABLE 100 Rest of Europe Heparin Market by Type, 2021 - 2027, USD Million
TABLE 101 Rest of Europe Heparin Market by Application, 2017 - 2020, USD Million
TABLE 102 Rest of Europe Heparin Market by Application, 2021 - 2027, USD Million
TABLE 103 Rest of Europe Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 104 Rest of Europe Unfractionated Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 105 Rest of Europe Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 106 Rest of Europe Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 107 Key Information – Baxter International, Inc.
TABLE 108 key Information – B. Braun Melsungen AG
TABLE 109 key information – Fresenius SE & Co. KGaA
TABLE 110 Key Information – Pfizer, Inc.
TABLE 111 Key Information – Sanofi S.A.
TABLE 112 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 113 key information – Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
TABLE 114 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 115 key information – LEO Pharma A/S
TABLE 116 key information – Viatris, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Fresenius SE & Co. KGaA